CFLT · As filed with the SEC

Confluent cash flow statement, by fiscal year

The statement as Confluent presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Cash Flows · USD thousands

USD thousands	FY2025 Year ended Dec 31, 2025	FY2024 Year ended Dec 31, 2024	FY2023 Year ended Dec 31, 2023	FY2022 Year ended Dec 31, 2022	FY2021 Year ended Dec 31, 2021	FY2020 Year ended Dec 31, 2020	FY2019 Year ended Dec 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	(295,275)	(345,065)	(442,746)	(452,551)	(342,801)	(229,828)	(95,042)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Depreciation and amortization	29,556	22,089	13,910	7,620	3,632	1,567	1,202
Net accretion of discounts on marketable securities	(22,300)	(37,766)	(42,505)	(8,891)	2,270	1,294	(787)
Amortization of debt issuance costs	3,839	3,836	3,813	3,799	187	0	0
Amortization of deferred contract acquisition costs	58,310	54,258	45,888	37,339	26,697	16,029	8,864
Non-cash operating lease costs	4,300	3,966	3,992	8,608	10,990	11,911	0
Lease abandonment charges	0	0	15,667	—	—	—	—
Common stock charitable donation expense	—	—	0	0	13,290,000	0	0
Stock-based compensation, net of amounts capitalized	397,325	395,660	349,833	277,656	155,624	143,341	18,617
Deferred income taxes	—	277,000	1,889,000	(237,000)	1,335,000	(1,335,000)	(394,000)
Deferred income taxes	(18,699)	—	—	—	—	—	—
Other	5,686	3,370	2,358	1,384	1,828	710	322
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	(79,718)	(86,562)	(53,593)	(42,080)	(32,516)	(41,612)	(27,117)
Deferred contract acquisition costs	(71,853)	(53,246)	(61,354)	(62,801)	(57,924)	(38,129)	(19,671)
Prepaid expenses and other assets	(25,394)	844	(10,387)	(17,850)	(31,366)	(14,368)	(5,926)
Accounts payable	13,466	127	(14,452)	13,580	6,143	(327)	1,511
Accrued expenses and other liabilities	(15,512)	25,639	61,333	9,948	61,132	15,837	8,604
Operating lease liabilities	(8,894)	(10,140)	(7,479)	(9,209)	(10,866)	(11,224)	0
Deferred revenue	89,437	56,173	30,176	76,352	87,285	64,077	40,983
Net cash provided by (used in) operating activities	64,274	33,460	(103,657)	(157,333)	(105,060)	(82,057)	(68,834)
CASH FLOWS FROM INVESTING ACTIVITIES
Capitalization of internal-use software costs	(22,558)	(21,404)	(17,845)	(10,334)	(5,342)	(3,610)	(975)
Purchases of marketable securities	(1,638,898)	(1,539,716)	(1,586,693)	(2,051,908)	(663,595)	(329,616)	(65,978)
Sales of marketable securities	6,144	15,311	—	0	0	4,988	33,104
Maturities of marketable securities	1,474,654	1,591,164	1,578,323	1,200,558	271,942	152,419	71,144
Purchases of investments in privately-held companies	(750)	(2,250)	—	—	—	—	—
Purchases of property and equipment	(3,597)	(2,567)	(2,834)	(4,121)	(3,600)	(1,040)	(1,954)
Cash paid for business combinations, net of cash acquired	0	(115,516)	(55,802)	—	—	—	—
Other	—	—	0	0	12,000	0	300,000
Net cash used in investing activities	(185,005)	(74,978)	(84,851)	(865,805)	(400,583)	(176,859)	35,641
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from initial public offering, net of underwriting discounts and commissions	—	—	0	0	786,600,000	0	0
Proceeds from issuance of common stock upon exercise of vested options	57,260	55,836	73,919	42,461	51,737	12,376	4,467
Proceeds from issuance of common stock upon early exercise of unvested options, net of repurchases	—	—	—	—	18,972,000	4,678,000	8,965,000
Proceeds from issuance of common stock upon early exercise of unvested options	—	0	0	416,000	—	4,765,000	—
Repurchases of unvested common stock	—	—	(255,000)	—	—	—	—
Payments of deferred offering costs	—	—	0	0	(3,125,000)	(111,000)	0
Proceeds from convertible senior notes, net of issuance costs	—	—	0	(786,000)	1,081,300,000	0	0
Payments for purchase of capped calls	—	—	0	0	(90,970,000)	0	0
Repurchases of unvested common stock	0	0	—	(789)	—	(87)	—
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs	—	—	—	0	0	259,815,000	0
Payments of debt issuance costs for convertible senior notes	—	0	—	—	—	—	—
Proceeds from issuance of common stock under employee stock purchase plan	23,926	23,970	28,708	40,939	—	0	—
Net cash provided by financing activities	81,186	79,806	102,372	82,241	1,844,514	276,758	13,432
Effect of exchange rate changes on cash and cash equivalents	—	(2,069,000)	116,000	(4,000)	5,000	(7,000)	(85,000)
Effect of exchange rate changes on cash and cash equivalents	775	—	—	—	—	—	—
Net (decrease) increase in cash and cash equivalents	(38,770)	36,219	(86,020)	(940,901)	1,338,876	17,835	(19,846)
Cash and cash equivalents at beginning of period	385,980	349,761	435,781	1,376,682	37,806	19,971	39,817
Cash and cash equivalents at end of period	347,210	385,980	349,761	435,781	1,376,682	37,806	19,971
Supplementary cash flow disclosures:
Cash paid for:
Income taxes	15,711	11,706	8,053	5,529	2,168	960	436
Non-cash investing and financing activities:
Stock-based compensation capitalized as internal-use software costs	16,623	19,891	17,943	7,544	2,625	547	69
Issuance of common stock in connection with a business combination	0	2,642	—	—	—	—	—
Right-of-use assets obtained in exchange for new operating lease liabilities	0	2,722	0	998	813	0	0
Property and equipment included in accounts payable and accrued expenses and other liabilities	—	—	—	0	0	203	60
Issuance of common stock upon exercise of vested options included in prepaid expenses and other current assets	—	—	0	0	55,000	54,000	0
Vesting of early exercised stock options	126	1,215	2,834	11,467	10,235	7,030	3,927
Conversion of convertible founder stock for Series E redeemable convertible preferred stock	—	—	—	0	0	109,035	0
Unpaid deferred offering costs	—	—	—	0	0	36	0
Convertible senior notes issuance costs included in accrued expenses and other liabilities	—	—	0	0	786,000	0	0

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.